A Phase I Study of Combination Duvelisib and Nivolumab in Patients With Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma, and Richter Transformation.

Saved in:
Bibliographic Details
Title: A Phase I Study of Combination Duvelisib and Nivolumab in Patients With Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma, and Richter Transformation.
Authors: Alsouqi A; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Huang Y; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Christian B; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Reneau J; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Bhat SA; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Brammer J; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Sawalha Y; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Baiocchi RA; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Grever M; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Rogers KA; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Reeser J; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Smith A; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Samorodnitsky E; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Roychowdhury S; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Maddocks K; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Woyach JA; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Bond D; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Source: European journal of haematology [Eur J Haematol] 2026 Mar; Vol. 116 (3), pp. 326-329. Date of Electronic Publication: 2025 Dec 09.
Publication Type: Letter
Journal Info: Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1600-0609
DOI:10.1111/ejh.70064